ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs MXN
17.77898
0.27%
Brent Oil
83.975
-0.43%
Bitcoin
63,692.93
-1.79%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Adamis Pharmaceuticals Corporation (ADMP)

  7. Adamis Pharmaceuticals Corporation (ADMP) Noticias

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADMP
FechaHoraFuenteTítuloSímboloCompañía
20/04/201715:01GlobeNewswire Inc.Adamis Pharmaceuticals Announces Proposed Public Offering of Common StockNASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/03/201717:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/03/201717:36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/02/201715:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/02/201705:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/02/201717:39Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/01/201708:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDANASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/12/201608:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDANASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/11/201616:54Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/09/201615:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/09/201605:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
23/09/201605:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/09/201613:26Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/08/201615:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/08/201614:15Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
04/08/201605:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
03/08/201608:00GlobeNewswire Inc.Adamis Pharmaceuticals Strengthens Patent Portfolio for its Dry Powder InhalerNASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/07/201616:22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/07/201607:45GlobeNewswire Inc.Adamis Pharmaceuticals Announces $11.1 Million Registered Direct OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/07/201608:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update On License Agreement with Allergan plc NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/07/201608:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Private PlacementNASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/06/201615:54Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/06/201605:45GlobeNewswire Inc.Adamis Pharmaceuticals Receives Complete Response Letter From FDA For Its Epinephrine Pre-Filled Syringe NDANASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/06/201605:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/05/201617:25Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/05/201605:45GlobeNewswire Inc.Adamis Pharmaceuticals Announces License Agreement with Allergan plc Subsidiary for Epinephrine Pre-Filled SyringeNASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/04/201605:05Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
22/04/201615:37Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/04/201605:45GlobeNewswire Inc.Adamis Pharmaceuticals Completes Acquisition of US CompoundingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/03/201605:45GlobeNewswire Inc.Adamis Pharmaceuticals Announces Agreement to Acquire US CompoundingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
NASDAQ
MSFT
Microsoft
FX
EURMXN
Euro vs MXN
NYSE
MCD
McDonalds
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
USOTC
BASFY
BASF (QX)
NYSE
AXP
American Express
COIN
BTCUSD
Bitcoin
AMEX
XLV
Health Care Select Sector
CCOM
US30
US 30
NASDAQ
AMZN
Amazon.com
FX
EURUSD
Euro vs US Dollar
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados